MOBICELL TRADE LTD
Company number 13160233 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
MOBICELL TRADE LTD - Analysis Report
Company Number: 13160233
Analysis Date: 2025-07-20 15:16 UTC
Financial Health Assessment of MOBICELL TRADE LTD (Year ended 29 February 2024)
1. Financial Health Score: B-
Explanation:
Mobicell Trade Ltd displays generally stable financial health with positive net assets and healthy liquidity, but there are some signs of potential concern, such as the significant increase in cash balances paired with a decrease in debtors and stock levels, and an increase in short-term liabilities, notably directors' loan accounts. The overall financial "vital signs" suggest a business in reasonable shape but with symptoms that warrant close monitoring and strategic adjustments.
2. Key Vital Signs
| Metric | 2024 Value (£) | 2023 Value (£) | Interpretation |
|---|---|---|---|
| Fixed Assets | 3,530 | 4,305 | Small tangible assets; slight reduction indicates limited capital investment or asset sales. |
| Current Assets | 80,488 | 78,623 | Stable current assets, showing liquidity is maintained. |
| Cash at Bank and in Hand | 67,648 | 10,183 | Strong improvement in cash holdings, a vital sign of healthy cash flow. |
| Debtors | 560 | 29,229 | Sharp drop in debtors; could mean faster collections or reduced sales on credit. |
| Stocks | 12,280 | 39,211 | Significant reduction in inventory, possibly reflecting more efficient stock management or lower sales volumes. |
| Current Liabilities | 41,829 | 33,313 | Increase in short-term obligations; mainly directors’ loan accounts increased markedly. |
| Net Current Assets | 38,659 | 45,310 | Healthy working capital but decreased by ~15%, signaling moderately tightening liquidity. |
| Net Assets / Shareholders’ Funds | 42,189 | 49,615 | Positive net worth but a decline, indicating some erosion of retained earnings or equity. |
3. Symptoms Analysis (What the numbers reveal)
- Healthy Cash Flow: The large increase in cash balance (from £10k to nearly £68k) is like a "strong pulse," signaling good cash inflows or cash management. However, the corresponding decrease in debtors and stock suggests possible changes in sales terms, customer base, or stock turnover.
- Rising Short-Term Debt: The increase in current liabilities, especially directors’ loans (from £20k to £31k), is a "symptom of reliance" on internal financing. This could indicate cash flow pressure requiring directors to inject funds temporarily—an important sign to watch.
- Declining Net Assets: The drop in net assets from £49.6k to £42.2k, while still positive, is a mild "symptom of financial stress" or reduced profitability/retained earnings.
- Lower Inventory and Debtors: These suggest the company may be tightening credit policies or experiencing reduced sales, which can be a positive sign for liquidity but might indicate slower business activity or risk of demand decline.
- Limited Fixed Assets: The small and slightly depreciated fixed assets base indicates a business model likely focused on trading rather than capital-intensive operations, which is typical for wholesale trade.
4. Diagnosis
Mobicell Trade Ltd is currently in a stable but cautious financial condition. The company maintains a healthy liquidity position, which is crucial for day-to-day operations, and strong positive net assets show it is solvent. However, the reliance on directors’ loans and the contraction in working capital metrics like stock and debtors suggest the business is experiencing some operational or sales challenges that require internal funding support.
The company is not in distress but shows early "symptoms" of tightening working capital and increasing short-term borrowing, which could evolve into stress if sales or cash generation do not improve.
5. Prognosis
If current trends continue—strong cash management paired with increased internal financing and reduced sales-related assets—the company could maintain operations but might face pressure to improve profitability and reduce reliance on director loans. The prognosis is cautiously optimistic, with a need for proactive management of sales growth and working capital.
6. Recommendations (Prescriptions for Financial Wellness)
- Enhance Sales and Credit Management: Investigate reasons for the sharp fall in debtors and stock. If sales are declining, consider marketing or pricing strategies to stimulate growth. If credit terms were tightened, monitor customer relationships to avoid lost opportunities.
- Reduce Reliance on Directors' Loans: Develop a plan to repay or convert director loans to equity to improve the balance sheet and reduce financial risk.
- Optimize Inventory Levels: Continue managing stock efficiently but ensure that inventory levels support anticipated sales without excess tying up cash.
- Monitor Cash Flow Closely: Maintain the current healthy cash position but watch for any fluctuations that could signal emerging liquidity issues.
- Plan for Capital Investment Cautiously: Fixed assets are minimal; consider whether strategic investment in assets could improve operational efficiency or sales capacity.
- Regular Financial Reviews: Conduct quarterly reviews to detect early signs of financial distress and adjust operations promptly.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.